BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonists

EMBO Journal

Volumn 23, Issue 11, 2004, Pages 2293-2303

  Wang, Sheng ^a   Zhang, Baohua ^a   Faller, Douglas V ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

E2F; SWI SNF; Tamoxifen; Transcription

Indexed keywords

ANTIESTROGEN; BRG1 PROTEIN; BRM PROTEIN; ESTROGEN; ESTROGEN RECEPTOR; PROHIBITIN; PROTEIN; TAMOXIFEN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER THERAPY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG RESISTANCE; ESTROGEN DEFICIENCY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION;

ANTHRACENES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; DNA HELICASES; ENZYME INHIBITORS; ESTROGEN ANTAGONISTS; FEMALE; FLOW CYTOMETRY; G1 PHASE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; LUCIFERASES; MITOGEN-ACTIVATED PROTEIN KINASE 8; NUCLEAR PROTEINS; PRECIPITIN TESTS; RECEPTORS, ESTROGEN; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; TAMOXIFEN; TRANSCRIPTION FACTORS;

EID: 3042680940     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.emboj.7600231     Document Type: Article

References (32)

1. Altus MS, Wood CM, Stewart DA, Roskams AJ, Friedman V, Henderson T, Owens GA, Danner DB, Jupe ER, Dell'Orco RT, McClung JK (1995) Regions of evolutionary conservation between the rat and human prohibitin-encoding genes. Gene 158: 291-294
2. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98: 13681-13686
3. Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, Wang W, Kashanchi F, Shiekhattar R (2000) BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer [In Process Citation]. Cell 102: 257-265
4. Carroll JS, Prall OW, Musgrove EA, Sutherland RL (2000) A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence. J Biol Chem 275: 38221-38229
5. Coezy E, Borgna JL, Rochefort H (1982) Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 42: 317-323
6. DiRenzo J, Shang Y, Phelan M, Sif S, Myers M, Kingston R, Brown M (2000) BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol Cell Biol 20: 7541-7549
7. Duh JL, Yu R, Jiao JJ, Matwyshyn GA, Li W, Tan TH, Kong AN (1997) Activation of signal transduction kinases by tamoxifen. Pharm Res 14: 186-189
8. Fujita T, Kobayashi Y, Wada O, Tateishi Y, Kitada L, Yamamoto Y, Takashima H, Murayama A, Yano T, Baba T, Kato S, Kawabe YI, Yanagisawa J (2003) Full activation of estrogen receptor alpha (ER alpha) activation function-1 (AF-1) induces proliferation of breast cancer cells. J Biol Chem 278 (29): 26704-26714
9. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, Davis RJ (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15: 2760-2770
10. Harbour JW, Dean DC (2000) The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 14: 2393-2409
11. Jost CA, Ginsberg D, Kaelin Jr WG (1996) A conserved region of unknown function participates in the recognition of E2F family members by the adenovirus E4 ORF 6/7 protein. Virology 220: 78-90
12. Lei K, Nimnual A, Zong WX, Kennedy NJ, Flavell RA, Thompson CB, Bar-Sagi D, Davis RJ (2002) The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol 22: 4929-4942
13. Li J, Gorospe M, Hutter D, Barnes J, Keyse SM, Liu Y (2001) Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. Mol Cell Biol 21: 8213-8224
14. Mandlekar S, Yu R, Tan TH, Kong AN (2000) Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Cancer Res 60:5995-6000
15. Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL, Karin M (1994) Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266: 1719-1723
16. Nagata K, Puls A, Futter C, Aspenstrom P, Schaefer E, Nakata T, Hirokawa N, Hall A (1998) The MAP kinase kinase kinase MLK2 co-localizes with activated JNK along microtubules and associates with kinesin superfamily motor KIF3. EMBO J 17: 149-158
17. Phelan DR, Price G, Liu YF, Dorow DS (2001) Activated JNK phosphorylates the c-terminal domain of MLK2 that is required for MLK2-induced apoptosis. J Biol Chem 276: 10801-10810
18. Rasmussen RK, Ji H, Eddes JS, Moritz RL, Reid GE, Simpson RJ, Dorow DS (1997) Two-dimensional electrophoretic analysis of human breast carcinoma proteins: mapping of proteins that bind to the SH3 domain of mixed lineage kinase MLK2. Electrophoresis 18: 588-598
19. Roskams AJ, Friedman V, Wood CM, Walker L, Owens GA, Stewart DA, Altus MS, Danner DB, Liu XT, McClung JK (1993) Cell cycle activity and expression of prohibitin mRNA. J Cell Physiol 157: 289-295
20. Sato T, Sakamoto T, Takita K, Saito H, Okui K, Nakamura Y (1993) The human prohibitin (PHB) gene family and its somatic mutations in human tumors. Genomics 17: 762-764
21. Strobeck MW, Knudsen KE, Fribourg AF, DeCristofaro MF, Weissman BE, Imbalzano AN, Knudsen ES (2000) BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci USA 97: 7748-7753
22. Strober BE, Dunaief JL, Guha S, Goff SP (1996) Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins. Mol Cell Biol 16: 1576-1583
23. Wang S, Fusaro G, Padmanabhan J, Chellappan SP (2002a) Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene 21: 8388-8396
24. Wang S, Ghosh RN, Chellappan SP (1998) Raf-1 physically interacts with Rb and regulates its function: a link between mitogenic signaling and cell cycle regulation. Mol Cell Biol 18: 7487-7498
25. Wang S, Nath N, Adlam M, Chellappan S (1999a) Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene 18: 3501-3510
26. Wang S, Nath N, Fusaro G, Chellappan S (1999b) Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol Cell Biol 19: 7447-7460
27. Wang S, Nath N, Minden A, Chellappan S (1999c) Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases. EMBO J 18: 1559-1570
28. Wang S, Zhang B, Faller DV (2002b) Prohibitin requires Brg-1/Brm for the repression of E2F and cell growth. EMBO J 21: 3019-3028
29. Wang W, Smith III R, Burghardt R, Safe SH (1997) 17 beta-Estradiol- mediated growth inhibition of MDA-MB-468 cells stably transfected with the estrogen receptor: cell cycle effects. Mol Cell Endocrinol 133: 49-62
30. Wolczynski S, Swiatecka J, Anchim T, Dabrowska M, Dzieciol J (2000) [Biochemical mechanism of raloxifen and tamoxifen action for the prevention of breast cancer. Studies in vitro]. Ginekol Pol 71: 1147-1152
31. Wong AK, Shanahan F, Chen Y, Lian L, Ha P, Hendricks K, Ghaffari S, Iliev D, Penn B, Woodland AM, Smith R, Salada G, Carillo A, Laity K, Gupte J, Swedlund B, Tavtigian SV, Teng DH, Lees E (2000) BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 60: 6171-6177
32. Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, Harbour JW, Dean DC (2000) Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101: 79-89